A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
Hexamethonium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexamethonium.
Potassium cation
Ifenprodil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ifenprodil.
Potassium cation
Indalpine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Indalpine.
Potassium cation
Amperozide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amperozide.
Potassium cation
Perospirone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perospirone.
Potassium cation
Lurasidone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lurasidone.
Potassium cation
Tofisopam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tofisopam.
Potassium cation
Cinitapride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cinitapride.
Potassium cation
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Potassium cation
Sulthiame
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sulthiame.
Potassium cation
Wortmannin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Wortmannin.
Potassium cation
Mebutamate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebutamate.
Potassium cation
Benzyl alcohol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzyl alcohol.
Potassium cation
Triclofos
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triclofos.
Potassium cation
Ketobemidone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketobemidone.
Potassium cation
Seproxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Seproxetine.
Potassium cation
Fospropofol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fospropofol.
Potassium cation
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dexmethylphenidate.
Potassium cation
Desvenlafaxine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desvenlafaxine.
Potassium cation
Nitrous oxide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nitrous oxide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3